BioCentriq, the New Jersey Innovation Institute’s cell and gene therapy development and manufacturing center, is partnering with Kytopen, a Cambridge-based startup spun out of Massachusetts Institute of Technology (MIT).
BioCentriq, the New Jersey Innovation Institute’s cell and gene therapy development and manufacturing center, has entered a partnership with Kytopen, a Cambridge, MA-based startup spun out of Massachusetts Institute of Technology (MIT).